메뉴 건너뛰기




Volumn 63, Issue , 2013, Pages 189-198

Contractile abnormalities and altered drug response in engineered heart tissue from Mybpc3-targeted knock-in mice

Author keywords

skAct; Acta1; Atp2a2; BPM; Cardiac myosin binding protein C (cMyBP C); CMyBP C; Disease modeling; EC50; EHT; EMD; EMD 57033; Engineered heart tissue (EHT); HCM; HET; IC50; IPSC; ISO; KI; LVIDd; LVIDs; LVMBW; Mybpc3; MYBPC3; Myh6; Myh7; Myofilament Ca2+ sensitivity; Slc8a1; T1; T2; TTP; TTP50; TTR50; TTR90

Indexed keywords

5 [1 (3,4 DIMETHOXYBENZOYL) 1,2,3,4 TETRAHYDRO 6 QUINOLYL] 3,6 DIHYDRO 6 METHYL 2H 1,3,4 THIADIAZIN 2 ONE; CALCIUM ION; FURA 2; ISOPRENALINE; MYOSIN BINDING PROTEIN C; VERAPAMIL;

EID: 84883277066     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2013.07.011     Document Type: Article
Times cited : (64)

References (35)
  • 1
    • 0029083650 scopus 로고
    • Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults
    • Maron B.J., Gardin J.M., Flack J.M., Gidding S.S., Kurosaki T.T., Bild D.E. Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults. Circulation 1995, 92:785-789.
    • (1995) Circulation , vol.92 , pp. 785-789
    • Maron, B.J.1    Gardin, J.M.2    Flack, J.M.3    Gidding, S.S.4    Kurosaki, T.T.5    Bild, D.E.6
  • 2
    • 38349086961 scopus 로고    scopus 로고
    • Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases
    • Elliott P., Andersson B., Arbustini E., Bilinska Z., Cecchi F., Charron P., et al. Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 2008, 29:270-276.
    • (2008) Eur Heart J , vol.29 , pp. 270-276
    • Elliott, P.1    Andersson, B.2    Arbustini, E.3    Bilinska, Z.4    Cecchi, F.5    Charron, P.6
  • 4
    • 84860498637 scopus 로고    scopus 로고
    • Genetics of hypertrophic and dilated cardiomyopathy
    • Friedrich F.W., Carrier L. Genetics of hypertrophic and dilated cardiomyopathy. Curr Pharm Biotechnol 2012, 13:2467-2476.
    • (2012) Curr Pharm Biotechnol , vol.13 , pp. 2467-2476
    • Friedrich, F.W.1    Carrier, L.2
  • 5
    • 79952071913 scopus 로고    scopus 로고
    • Cardiac myosin-binding protein C in hypertrophic cardiomyopathy: mechanisms and therapeutic opportunities
    • Schlossarek S., Mearini G., Carrier L. Cardiac myosin-binding protein C in hypertrophic cardiomyopathy: mechanisms and therapeutic opportunities. J Mol Cell Cardiol 2011, 50:613-620.
    • (2011) J Mol Cell Cardiol , vol.50 , pp. 613-620
    • Schlossarek, S.1    Mearini, G.2    Carrier, L.3
  • 7
    • 81255179602 scopus 로고    scopus 로고
    • ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
    • Gersh B.J., Maron B.J., Bonow R.O., Dearani J.A., Fifer M.A., Link M.S., et al. ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Thorac Cardiovasc Surg 2011, 142:e153-e203.
    • (2011) J Thorac Cardiovasc Surg , vol.142
    • Gersh, B.J.1    Maron, B.J.2    Bonow, R.O.3    Dearani, J.A.4    Fifer, M.A.5    Link, M.S.6
  • 8
    • 78649929399 scopus 로고    scopus 로고
    • Insights into genotype-phenotype correlation in hypertrophic cardiomyopathy. Findings from 18 Spanish families with a single mutation in MYBPC3
    • Oliva-Sandoval M.J., Ruiz-Espejo F., Monserrat L., Hermida-Prieto M., Sabater M., Garcia-Molina E., et al. Insights into genotype-phenotype correlation in hypertrophic cardiomyopathy. Findings from 18 Spanish families with a single mutation in MYBPC3. Heart 2010, 96:1980-1984.
    • (2010) Heart , vol.96 , pp. 1980-1984
    • Oliva-Sandoval, M.J.1    Ruiz-Espejo, F.2    Monserrat, L.3    Hermida-Prieto, M.4    Sabater, M.5    Garcia-Molina, E.6
  • 9
    • 77949718853 scopus 로고    scopus 로고
    • Hypertrophic cardiomyopathy: from genetics to treatment
    • Marian A.J. Hypertrophic cardiomyopathy: from genetics to treatment. Eur J Clin Invest 2010, 40:360-369.
    • (2010) Eur J Clin Invest , vol.40 , pp. 360-369
    • Marian, A.J.1
  • 10
    • 67650086995 scopus 로고    scopus 로고
    • A new polymorphism in human calmodulin III gene promoter is a potential modifier gene for familial hypertrophic cardiomyopathy
    • Friedrich F.W., Bausero P., Sun Y., Treszl A., Kramer E., Juhr D., et al. A new polymorphism in human calmodulin III gene promoter is a potential modifier gene for familial hypertrophic cardiomyopathy. Eur Heart J 2009, 30:1648-1655.
    • (2009) Eur Heart J , vol.30 , pp. 1648-1655
    • Friedrich, F.W.1    Bausero, P.2    Sun, Y.3    Treszl, A.4    Kramer, E.5    Juhr, D.6
  • 11
    • 58149328530 scopus 로고    scopus 로고
    • Diastolic abnormalities as the first feature of hypertrophic cardiomyopathy in Dutch myosin-binding protein C founder mutations
    • Michels M., Soliman O.I., Kofflard M.J., Hoedemaekers Y.M., Dooijes D., Majoor-Krakauer D., et al. Diastolic abnormalities as the first feature of hypertrophic cardiomyopathy in Dutch myosin-binding protein C founder mutations. JACC Cardiovasc Imaging 2009, 2:58-64.
    • (2009) JACC Cardiovasc Imaging , vol.2 , pp. 58-64
    • Michels, M.1    Soliman, O.I.2    Kofflard, M.J.3    Hoedemaekers, Y.M.4    Dooijes, D.5    Majoor-Krakauer, D.6
  • 12
    • 58449108642 scopus 로고    scopus 로고
    • Biomarkers of pathophysiology in hypertrophic cardiomyopathy: implications for clinical management and prognosis
    • Cambronero F., Marin F., Roldan V., Hernandez-Romero D., Valdes M., Lip G.Y. Biomarkers of pathophysiology in hypertrophic cardiomyopathy: implications for clinical management and prognosis. Eur Heart J 2009, 30:139-151.
    • (2009) Eur Heart J , vol.30 , pp. 139-151
    • Cambronero, F.1    Marin, F.2    Roldan, V.3    Hernandez-Romero, D.4    Valdes, M.5    Lip, G.Y.6
  • 13
    • 33747195353 scopus 로고    scopus 로고
    • Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors
    • Takahashi K., Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126:663-676.
    • (2006) Cell , vol.126 , pp. 663-676
    • Takahashi, K.1    Yamanaka, S.2
  • 14
    • 77957729169 scopus 로고    scopus 로고
    • Patient-specific induced pluripotent stem-cell models for long-QT syndrome
    • Moretti A., Bellin M., Welling A., Jung C.B., Lam J.T., Bott-Flugel L., et al. Patient-specific induced pluripotent stem-cell models for long-QT syndrome. N Engl J Med 2010, 363:1397-1409.
    • (2010) N Engl J Med , vol.363 , pp. 1397-1409
    • Moretti, A.1    Bellin, M.2    Welling, A.3    Jung, C.B.4    Lam, J.T.5    Bott-Flugel, L.6
  • 16
    • 84860156650 scopus 로고    scopus 로고
    • Patient-specific induced pluripotent stem cells as a model for familial dilated cardiomyopathy
    • Sun N., Yazawa M., Liu J., Han L., Sanchez-Freire V., Abilez O.J., et al. Patient-specific induced pluripotent stem cells as a model for familial dilated cardiomyopathy. Sci Transl Med 2012, 4:130ra47.
    • (2012) Sci Transl Med , vol.4
    • Sun, N.1    Yazawa, M.2    Liu, J.3    Han, L.4    Sanchez-Freire, V.5    Abilez, O.J.6
  • 17
    • 84872026086 scopus 로고    scopus 로고
    • Abnormal calcium handling properties underlie familial hypertrophic cardiomyopathy pathology in patient-specific induced pluripotent stem cells
    • Lan F., Lee A.S., Liang P., Sanchez-Freire V., Nguyen P.K., Wang L., et al. Abnormal calcium handling properties underlie familial hypertrophic cardiomyopathy pathology in patient-specific induced pluripotent stem cells. Cell Stem Cell 2013, 12:101-113.
    • (2013) Cell Stem Cell , vol.12 , pp. 101-113
    • Lan, F.1    Lee, A.S.2    Liang, P.3    Sanchez-Freire, V.4    Nguyen, P.K.5    Wang, L.6
  • 18
    • 77954760209 scopus 로고    scopus 로고
    • Development of a drug screening platform based on engineered heart tissue
    • Hansen A., Eder A., Bonstrup M., Flato M., Mewe M., Schaaf S., et al. Development of a drug screening platform based on engineered heart tissue. Circ Res 2010, 107:35-44.
    • (2010) Circ Res , vol.107 , pp. 35-44
    • Hansen, A.1    Eder, A.2    Bonstrup, M.3    Flato, M.4    Mewe, M.5    Schaaf, S.6
  • 19
    • 80054783465 scopus 로고    scopus 로고
    • Human engineered heart tissue as a versatile tool in basic research and preclinical toxicology
    • Schaaf S., Shibamiya A., Mewe M., Eder A., Stohr A., Hirt M.N., et al. Human engineered heart tissue as a versatile tool in basic research and preclinical toxicology. PLoS One 2011, 6:e26397.
    • (2011) PLoS One , vol.6
    • Schaaf, S.1    Shibamiya, A.2    Mewe, M.3    Eder, A.4    Stohr, A.5    Hirt, M.N.6
  • 20
    • 68249092692 scopus 로고    scopus 로고
    • Nonsense-mediated mRNA decay and ubiquitin-proteasome system regulate cardiac myosin-binding protein C mutant levels in cardiomyopathic mice
    • Vignier N., Schlossarek S., Fraysse B., Mearini G., Kramer E., Pointu H., et al. Nonsense-mediated mRNA decay and ubiquitin-proteasome system regulate cardiac myosin-binding protein C mutant levels in cardiomyopathic mice. Circ Res 2009, 105:239-248.
    • (2009) Circ Res , vol.105 , pp. 239-248
    • Vignier, N.1    Schlossarek, S.2    Fraysse, B.3    Mearini, G.4    Kramer, E.5    Pointu, H.6
  • 21
    • 84860522221 scopus 로고    scopus 로고
    • Increased myofilament Ca(2+) sensitivity and diastolic dysfunction as early consequences of Mybpc3 mutation in heterozygous knock-in mice
    • Fraysse B., Weinberger F., Bardswell S.C., Cuello F., Vignier N., Geertz B., et al. Increased myofilament Ca(2+) sensitivity and diastolic dysfunction as early consequences of Mybpc3 mutation in heterozygous knock-in mice. J Mol Cell Cardiol 2012, 52:1299-1307.
    • (2012) J Mol Cell Cardiol , vol.52 , pp. 1299-1307
    • Fraysse, B.1    Weinberger, F.2    Bardswell, S.C.3    Cuello, F.4    Vignier, N.5    Geertz, B.6
  • 23
    • 0027453927 scopus 로고
    • Stereoselective actions of thiadiazinones on canine cardiac myocytes and myofilaments
    • Solaro R.J., Gambassi G., Warshaw D.M., Keller M.R., Spurgeon H.A., Beier N., et al. Stereoselective actions of thiadiazinones on canine cardiac myocytes and myofilaments. Circ Res 1993, 73:981-990.
    • (1993) Circ Res , vol.73 , pp. 981-990
    • Solaro, R.J.1    Gambassi, G.2    Warshaw, D.M.3    Keller, M.R.4    Spurgeon, H.A.5    Beier, N.6
  • 24
    • 4444368240 scopus 로고    scopus 로고
    • Roles of phosphorylation of myosin binding protein-C and troponin I in mouse cardiac muscle twitch dynamics
    • Tong C.W., Gaffin R.D., Zawieja D.C., Muthuchamy M. Roles of phosphorylation of myosin binding protein-C and troponin I in mouse cardiac muscle twitch dynamics. J Physiol 2004, 558:927-941.
    • (2004) J Physiol , vol.558 , pp. 927-941
    • Tong, C.W.1    Gaffin, R.D.2    Zawieja, D.C.3    Muthuchamy, M.4
  • 25
    • 37349023159 scopus 로고    scopus 로고
    • Cardiac myosin-binding protein C is required for complete relaxation in intact myocytes
    • Pohlmann L., Kroger I., Vignier N., Schlossarek S., Kramer E., Coirault C., et al. Cardiac myosin-binding protein C is required for complete relaxation in intact myocytes. Circ Res 2007, 101:928-938.
    • (2007) Circ Res , vol.101 , pp. 928-938
    • Pohlmann, L.1    Kroger, I.2    Vignier, N.3    Schlossarek, S.4    Kramer, E.5    Coirault, C.6
  • 26
    • 79960001856 scopus 로고    scopus 로고
    • Neonatal mouse-derived engineered cardiac tissue: a novel model system for studying genetic heart disease
    • de Lange W.J., Hegge L.F., Grimes A.C., Tong C.W., Brost T.M., Moss R.L., et al. Neonatal mouse-derived engineered cardiac tissue: a novel model system for studying genetic heart disease. Circ Res 2011, 109:8-19.
    • (2011) Circ Res , vol.109 , pp. 8-19
    • de Lange, W.J.1    Hegge, L.F.2    Grimes, A.C.3    Tong, C.W.4    Brost, T.M.5    Moss, R.L.6
  • 27
    • 84872236380 scopus 로고    scopus 로고
    • Ablation of cardiac myosin-binding protein-C accelerates contractile kinetics in engineered cardiac tissue
    • de Lange W.J., Grimes A.C., Hegge L.F., Ralphe J.C. Ablation of cardiac myosin-binding protein-C accelerates contractile kinetics in engineered cardiac tissue. J Gen Physiol 2013, 141:73-84.
    • (2013) J Gen Physiol , vol.141 , pp. 73-84
    • de Lange, W.J.1    Grimes, A.C.2    Hegge, L.F.3    Ralphe, J.C.4
  • 29
    • 44949259297 scopus 로고    scopus 로고
    • Myofilament protein gene mutation screening and outcome of patients with hypertrophic cardiomyopathy
    • Olivotto I., Girolami F., Ackerman M.J., Nistri S., Bos J.M., Zachara E., et al. Myofilament protein gene mutation screening and outcome of patients with hypertrophic cardiomyopathy. Mayo Clin Proc 2008, 83:630-638.
    • (2008) Mayo Clin Proc , vol.83 , pp. 630-638
    • Olivotto, I.1    Girolami, F.2    Ackerman, M.J.3    Nistri, S.4    Bos, J.M.5    Zachara, E.6
  • 30
    • 72949085057 scopus 로고    scopus 로고
    • The ubiquitin-proteasome system and nonsense-mediated mRNA decay in hypertrophic cardiomyopathy
    • Carrier L., Schlossarek S., Willis M.S., Eschenhagen T. The ubiquitin-proteasome system and nonsense-mediated mRNA decay in hypertrophic cardiomyopathy. Cardiovasc Res 2010, 85:330-338.
    • (2010) Cardiovasc Res , vol.85 , pp. 330-338
    • Carrier, L.1    Schlossarek, S.2    Willis, M.S.3    Eschenhagen, T.4
  • 33
    • 47749102476 scopus 로고    scopus 로고
    • Cardiac myosin-binding protein C modulates the tuning of the molecular motor in the heart
    • Lecarpentier Y., Vignier N., Oliviero P., Guellich A., Carrier L., Coirault C. Cardiac myosin-binding protein C modulates the tuning of the molecular motor in the heart. Biophys J 2008, 95:720-728.
    • (2008) Biophys J , vol.95 , pp. 720-728
    • Lecarpentier, Y.1    Vignier, N.2    Oliviero, P.3    Guellich, A.4    Carrier, L.5    Coirault, C.6
  • 34
    • 2442698889 scopus 로고    scopus 로고
    • Role of cardiac myosin binding protein C in sustaining left ventricular systolic stiffening
    • Palmer B.M., Georgakopoulos D., Janssen P.M., Wang Y., Alpert N.R., Belardi D.F., et al. Role of cardiac myosin binding protein C in sustaining left ventricular systolic stiffening. Circ Res 2004, 94:1249-1255.
    • (2004) Circ Res , vol.94 , pp. 1249-1255
    • Palmer, B.M.1    Georgakopoulos, D.2    Janssen, P.M.3    Wang, Y.4    Alpert, N.R.5    Belardi, D.F.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.